Filing Details

Accession Number:
0001209191-16-138029
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-08-19 19:15:54
Reporting Period:
2016-08-18
Filing Date:
2016-08-19
Accepted Time:
2016-08-19 19:15:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1305253 Eiger Biopharmaceuticals Inc. EIGR Biological Products, (No Disgnostic Substances) (2836) 361004130
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1670137 A David Cory 350 Cambridge Ave, Suite 350
Palo Alto CA 94306
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-08-18 1,562 $15.70 58,451 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 30,350 Indirect See footnote 1
Footnotes
  1. Represents the Reporting Person's proportionate interest in securities held by Eiccose, LLC ("Eiccose"). The Reporting Person is a managing member and significant equity interest holder of Eiccose. The Reporting Person hereby disclaims any beneficial ownership of any shares directly held by Eiccose, except to the extent of its pecuniary interest therein.